Advances in VR Technology
(2020)
Advances in VR Technology: pp.
-.
Chapter 12
Cost-effectiveness analysis of bortezomib in combination with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone (VR-CAP) in patients with previously untreated mantle cell lymphoma